Thank you to our 2022 PEDS attendees!

Please stay tuned for details about the 2023 Pediatric Early Development Symposium.

In the meantime, we invite you to review the 2022 PEDS Impact Report below.

What is PEDS?

Launched in 2020 in response to the passage of Title V of the FDA Reauthorization Act, commonly known as the RACE for Children Act, the CureSearch Pediatric Early Development Symposium (PEDS) serves as an opportunity for industry, academia and regulatory leaders to examine the dynamic nature of clinical trials for a super rare population - children with cancer.

Each subsequent PEDS has built upon the last, returning participants to a mindset of advancing pediatric cancer clinical trials and exploring resources, infrastructure, collaborations and – in 2022 – technological integrations that make clinical trials for rare patient populations more robust and efficient. Register to join us here.

Symposium Co-Chairs

Jeffrey Skolnik, PhD

Jeffrey Skolnik, MD
Vice President,
Clinical Development
INOVIO Pharmaceuticals

Brenda Weigel

Brenda Weigel, MD
Director of the Division of
Pediatric Hematology/Oncology,
University of Minnesota's Masonic Cancer Center

Working Group Members

Elizabeth Fox, MD St. Jude Children's Research Hospital Memphis, TN
Elizabeth Fox, MD, MSc
Senior Vice President, Clinical Trials Research
St. Jude Children's Research Hospital
Gregory Reaman
Gregory Reaman, MD
Associate Director for Oncology Sciences
Center for Drug Evaluation & Research, U.S. FDA

Kannan Headshot 2020 (1)
Geoffrey Kannan, MD
Senior Mediacal Director
Labcorp Drug Development
Mark Kieran, MD, PhD
Vice President of Clinical Development
Day One Biopharmaceuticals

Isaac R_C Headshot
Isaac Rodriguez-Chavez, PhD, MHSc, MSc
Senior Vice President, Scientific & Clinical Affairs
ICON plc


Industry leaders, academics and other thought leaders in pediatric drug development.

- Medical Affairs
- Clinical Affairs
- Project Management
- Regulatory Affairs
- Research and Development
- Early Development
- Late Development

- Clinical Operations
- Executives
- Management
- Academic
- Patient Advocates
- Regulators
- Other key opinion leaders



To learn more about becoming a sponsor for the 2022 Pediatric Early Development Symposium, please contact

Pin It on Pinterest

Scroll to Top